Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DIVIS LABORATORIES vs EARUM PHARMACEUTICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DIVIS LABORATORIES EARUM PHARMACEUTICALS DIVIS LABORATORIES/
EARUM PHARMACEUTICALS
 
P/E (TTM) x 66.0 -41.4 - View Chart
P/BV x 7.1 1.9 378.3% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 DIVIS LABORATORIES   EARUM PHARMACEUTICALS
EQUITY SHARE DATA
    DIVIS LABORATORIES
Mar-23
EARUM PHARMACEUTICALS
Mar-23
DIVIS LABORATORIES/
EARUM PHARMACEUTICALS
5-Yr Chart
Click to enlarge
High Rs4,6418 55,915.1%   
Low Rs2,7302 140,721.6%   
Sales per share (Unadj.) Rs292.62.3 12,805.8%  
Earnings per share (Unadj.) Rs68.70.3 21,385.6%  
Cash flow per share (Unadj.) Rs81.60.3 24,143.1%  
Dividends per share (Unadj.) Rs30.000-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs480.93.0 15,856.8%  
Shares outstanding (eoy) m265.4761.68 430.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x12.62.2 562.1%   
Avg P/E ratio x53.715.9 336.6%  
P/CF ratio (eoy) x45.215.1 298.1%  
Price / Book Value ratio x7.71.7 453.9%  
Dividend payout %43.70-   
Avg Mkt Cap Rs m978,378316 309,811.8%   
No. of employees `000NANA-   
Total wages/salary Rs m9,7501 1,282,921.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m77,675141 55,116.1%  
Other income Rs m3,44723 15,230.2%   
Total revenues Rs m81,122164 49,600.6%   
Gross profit Rs m23,6919 255,567.4%  
Depreciation Rs m3,4321 329,980.8%   
Interest Rs m203 675.9%   
Profit before tax Rs m23,68628 84,745.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,4538 66,984.0%   
Profit after tax Rs m18,23420 92,043.4%  
Gross profit margin %30.56.6 463.7%  
Effective tax rate %23.029.1 79.0%   
Net profit margin %23.514.1 167.0%  
BALANCE SHEET DATA
Current assets Rs m97,437281 34,666.6%   
Current liabilities Rs m15,33199 15,539.0%   
Net working cap to sales %105.7129.4 81.7%  
Current ratio x6.42.8 223.1%  
Inventory Days Days80-  
Debtors Days Days8422,173 38.8%  
Net fixed assets Rs m51,1285 1,071,863.7%   
Share capital Rs m531123 430.4%   
"Free" reserves Rs m127,14064 199,560.5%   
Net worth Rs m127,671187 68,247.7%   
Long term debt Rs m00-   
Total assets Rs m148,565286 51,975.0%  
Interest coverage x1,209.510.6 11,365.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.50.5 106.0%   
Return on assets %12.37.9 154.6%  
Return on equity %14.310.6 134.9%  
Return on capital %18.616.5 112.6%  
Exports to sales %85.70-   
Imports to sales %19.80-   
Exports (fob) Rs m66,537NA-   
Imports (cif) Rs m15,378NA-   
Fx inflow Rs m66,5370-   
Fx outflow Rs m15,7150-   
Net fx Rs m50,8220-   
CASH FLOW
From Operations Rs m24,5973 935,258.6%  
From Investments Rs m-27,076NA-  
From Financial Activity Rs m-7,972-3 274,886.2%  
Net Cashflow Rs m-10,4510 3,732,357.1%  

Share Holding

Indian Promoters % 51.9 0.0 -  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.7 0.0 -  
FIIs % 14.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.1 100.0 48.1%  
Shareholders   354,482 52,415 676.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DIVIS LABORATORIES With:   CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Divis Laboratories vs EARUM PHARMACEUTICALS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Divis Laboratories vs EARUM PHARMACEUTICALS Share Price Performance

Period Divis Laboratories EARUM PHARMACEUTICALS S&P BSE HEALTHCARE
1-Day 2.14% -4.67% 1.18%
1-Month -2.15% -40.42% -0.75%
1-Year 22.51% -32.55% 61.82%
3-Year CAGR -1.38% -41.46% 18.16%
5-Year CAGR 15.77% -16.88% 19.79%

* Compound Annual Growth Rate

Here are more details on the Divis Laboratories share price and the EARUM PHARMACEUTICALS share price.

Moving on to shareholding structures...

The promoters of Divis Laboratories hold a 51.9% stake in the company. In case of EARUM PHARMACEUTICALS the stake stands at 0.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Divis Laboratories and the shareholding pattern of EARUM PHARMACEUTICALS.

Finally, a word on dividends...

In the most recent financial year, Divis Laboratories paid a dividend of Rs 30.0 per share. This amounted to a Dividend Payout ratio of 43.7%.

EARUM PHARMACEUTICALS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of Divis Laboratories, and the dividend history of EARUM PHARMACEUTICALS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.